KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Invested Capital (2017 - 2025)

Sarepta Therapeutics (SRPT) has 8 years of Return on Invested Capital data on record, last reported at 0.07% in Q4 2024.

  • For Q4 2024, Return on Invested Capital rose 21.0% year-over-year to 0.07%; the TTM value through Dec 2024 reached 0.07%, up 21.0%, while the annual FY2024 figure was 0.08%, 22.0% up from the prior year.
  • Return on Invested Capital reached 0.07% in Q4 2024 per SRPT's latest filing, up from 0.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q4 2024 and bottomed at 0.68% in Q1 2020.
  • Average Return on Invested Capital over 5 years is 0.32%, with a median of 0.32% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: crashed -40bps in 2020, then grew 29bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.52% in 2020, then rose by 30bps to 0.36% in 2021, then increased by 20bps to 0.29% in 2022, then skyrocketed by 52bps to 0.14% in 2023, then skyrocketed by 152bps to 0.07% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.07% in Q4 2024, 0.03% in Q3 2024, and 0.02% in Q2 2024.